[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342183-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342183-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","member-adherence-to-a-health-insurer-sponsored-gap-closure-program-using-multi-target-stool-dna-test-for-colorectal-cancer-screening","Member Adherence to a Health Insurer-Sponsored Gap Closure Program Using Multi-Target Stool DNA Test for Colorectal Cancer Screening","","Objectives describe member adherence to a mail-based, health insurer-sponsored gap closure program for colorectal cancer screening using multi-target stool DNA (mt-sDNA; Cologuard) tests. Methods combine patient data from Exact Sciences Laboratories and records of mass-mailed mt-sDNA orders from a large Medicare Advantage plan, evaluating adherence and time to test return. Multivariable regression assesses associations with patient characteristics. Results include 49.4% adherence and a mean 25.5-day return time, with higher return odds among ages 65–75, small-town residents, and patients receiving digital outreach. Conclusions link mass-mailed mt-sDNA screening to roughly 50% adherence and greater test return with digital outreach.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/member-adherence-to-a-health-insurer-sponsored-gap-closure-program-using-multi-target-stool-dna-test-for-colorectal-cancer-screening/342183/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/member-adherence-to-a-health-insurer-sponsored-gap-closure-program-using-multi-target-stool-dna-test-for-colorectal-cancer-screening/342183.png","ImageObject",300,407,{"name":42,"@type":43},"Clementine","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-07","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What was the objective of the study?","Question",{"text":63,"@type":64},"To describe member adherence to a mail-based, health insurer-sponsored gap closure program for colorectal cancer screening using multi-target stool DNA (mt-sDNA) tests.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were adherence and test return time measured?",{"text":68,"@type":64},"Combined patient data were analyzed from Exact Sciences Laboratories and from mass-mailed mt-sDNA orders placed by a large Medicare Advantage plan. Adherence and time to test return were the primary and secondary outcomes, respectively.",{"name":70,"@type":61,"acceptedAnswer":71},"Which factors were associated with higher odds of test return?",{"text":72,"@type":64},"After adjustment, odds of test return were higher for adults aged 65–75, those living in small towns, and patients who received digital outreach via both SMS and email.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342183,1790562865,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":106,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},1374391974564,"https://ap-avatar.wpscdn.com/avatar/14000253aa45c000a9e?x-image-process=image/resize,m_fixed,w_180,h_180&k=1779874745381141002","Member Adherence to a Health Insurer-Sponsored Gap Closure Program Using Multi-Target Stool DNA Test for Colorectal Cancer Screening  \nJournal of Primary Care & Community Health Volume 15: 1–7  \n© The Author(s) 2024  \nArticle reuse guidelines: [sagepub.com/journals-permissions](sagepub.com/journals-permissions)[ ](sagepub.com/journals-permissions)[DOI: 10.1177/21501319241305958](DOI: 10.1177/21501319241305958)[ ](DOI: 10.1177/21501319241305958)[journals.sagepub.com/home/jpc](journals.sagepub.com/home/jpc)  \nMallik Greene 1, Timo Pew 1, Quang Le 1, Alisdair Philp 1, William K. Johnson 1, A. Burak Ozbay 1, John Kisiel2, Michael Dore3, Derek Ebner2, A. Mark Fendrick4, and Paul Limburg 1  \nAbstract  \nObjectives: To describe member adherence to a mail-based, health insurer-sponsored gap closure program for colorectal cancer (CRC) screening using multi-target stool DNA (mt-sDNA; Cologuard® ) tests. Methods: Combined patient data from Exact Sciences Laboratories LLC and data from mass-mailed mt-sDNA orders placed by a large Medicare Advantage Insurance Plan were analyzed (03/01/2023-06/30/2023). Adherence and time to test return were the primary and secondary outcomes, respectively. Their association with patient characteristics was evaluated using multivariable regression. Results: Among the 3201 member-patients included (86.6% aged 65-75 years; 58.7% female), adherence rate was 49.4%, and mean time to test return was 25.5 days. After multivariable adjustment, the odds of test return were significantly higher among 65-to 75-year-olds (odds ratio [OR] = 1.59 relative to 45-to 64-year-olds), those living in small towns (OR = 1.43 relative to metropolitan-located individuals), and with digital outreach via both SMS and email (OR = 4.31 relative to no digital outreach). Time to test return was shorter in 65-to 75-year-olds than in 45-to 64-year-olds and was not associated with other patient characteristics. Conclusions: Mass-mailed mt-sDNA tests for CRC screening were associated with an overall adherence rate of about 50% in this Medicare Advantage population, with higher likelihood of test return among patients receiving digital outreach.  \nKeywords  \ncologuard, colorectal cancer screening, colorectal neoplasms, insurance, Medicare Advantage, mt-sDNA  \nDates received: 26 September 2024; revised: 19 November 2024; accepted: 22 November 2024.  \nIntroduction  \nColorectal cancer (CRC) is the second leading cause of cancer-related deaths in the United States (US) and is estimated to account for 8.7% of all cancer-related deaths in the US in 2024. 1,2 Early detection of CRC through screening can help improve outcomes.3 Previously, the US Preventive Services Task Force (USPSTF) recommended all adults aged 50 to 75 years be screened for CRC; in 2021, this age range was revised to 45 to 75 years.4  \nGuideline-recommended CRC screening modalities include endoscopic methods, such as colonoscopy or sigmoidoscopy, and less invasive, stool-based tests that can be performed at home, such as high-sensitivity guaiac fecal occult blood testing (gFOBT), fecal  \nimmunochemical test (FIT), and multi-target stool DNA (mt-sDNA) test (marketed as the Cologuard® test; Exact Sciences, Madison, WI) .5,6 Access to screening is crucial to the early detection of CRC, which may help reduce subsequent health and financial burden on patients,7 and adherence to screening recommendations is also critical  \n1 Exact Sciences Corporation, Madison, WI, USA 2Mayo Clinic, Rochester, MN, USA  \n3Duke University, Durham, NC, USA 4University of Michigan, Ann Arbor, MI, USA  \nCorresponding Author:  \nMallik Greene, Medical Affairs, Exact Sciences Corporation, 5505 Endeavor Lane, Madison, WI 53719, USA. [Email: magreene@exactsciences.com](Email: magreene@exactsciences.com)  \nCreative Commons Non Commercial CC BY-NC: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License ([https://creativecommons.org/licenses/by-nc/4.0/](https://crea","cbCaijPmpOMQOJd8","https://ap.wps.com/l/cbCaijPmpOMQOJd8","pdf",395336,"English","# Abstract\n## Objectives\n## Methods\n## Results\n## Conclusions\n# Introduction\n## Background and screening guidelines\n## Rationale for outreach and completion","[{\"question\":\"What was the objective of the study?\",\"answer\":\"To describe member adherence to a mail-based, health insurer-sponsored gap closure program for colorectal cancer screening using multi-target stool DNA (mt-sDNA) tests.\"},{\"question\":\"How were adherence and test return time measured?\",\"answer\":\"Combined patient data were analyzed from Exact Sciences Laboratories and from mass-mailed mt-sDNA orders placed by a large Medicare Advantage plan. Adherence and time to test return were the primary and secondary outcomes, respectively.\"},{\"question\":\"Which factors were associated with higher odds of test return?\",\"answer\":\"After adjustment, odds of test return were higher for adults aged 65–75, those living in small towns, and patients who received digital outreach via both SMS and email.\"}]","Member Adherence to a Health Insurer-Sponsored Gap Closure Program Using Multi-Target Stool DNA Test for Colorectal Cancer Screening | PDF",1790045725,18,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5ad17248a9f04a28900486f07f7c6162.webp",983,1276,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/89e731b10ec3edd1901400720714a75d.webp",982,1275,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce723cf805ff5ffbcb551527fdd89f18.webp",981,1273,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9a98299430b6663fc84db81a33059a4a.webp",980,1272]